Accueil > Actualité
Actualite financiere : Actualite bourse

Sanofi: positive results for Toujeo in diabetes

( - Sanofi has announced positive results of a phase III trial for Toujeo in the treatment of Type 1 diabetes in children and adolescents, at the Congress of the International Society for Pediatric and Adolescent Diabetes in Boston.

Patients aged 6 to 17 years old treated with Toujeo (insulin glargine 300 units/ml) achieved a comparable reduction in their average blood sugar level and presented the same risks of hypoglycaemia episodes as those treated with glargine 100 units/ml.

On this basis, the CHMP of the European Medicines Agency has recommended the extension of its current indication for Toujeo to children and adolescents with Type 1 diabetes. The European Commission will make its final decision in the coming months.

Copyright (c) 2019 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.